Advertisement
Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites

Serum Cystatin C Predicts Mortality With Cirrhotic Ascites

0
Creatinine levels not tied to mortality or type 1 hepatorenal syndrome
The apolipoprotein E (APOE) ε4 allele increases the risk of overall and cardiovascular mortality

APOE Allele Type Tied to Mortality Risk

0
No racial difference in the association between these alleles and mortality
Air pollution may lead to kidney damage

Air Pollution May Damage Kidneys

0
Study finds link between particulate matter and renal function
Adipochemokines induced by ultraviolet light may play a role in reduction of lipogenesis in subcutaneous fat

UV Exposure May Contribute to Impaired Fat Homeostasis

0
UV exposure induces specific adipochemokines in SC fat, including C-X-C chemokines, C-C chemokines
A combination antibody strategy could be the key to halting the spread of HIV

Combination Strategy Could Be Key in HIV Prevention

0
Research supports need for regimens that protect against several targets
Children with inflammatory bowel disease face an increased risk of cancer that persists into adulthood

Childhood-Onset IBD May Raise Risk of Cancer

0
Researchers think chronic inflammation in gastrointestinal tract may be driving force
Proton pump inhibitors are overused worldwide

Proton Pump Inhibitors Overused Worldwide

0
Wide variation in inappropriate use documented in the international literature, from 11 to 84 percent
General and central obesity are associated with breast cancer risk

General, Central Obesity Linked to Specific Breast Cancer Risk

0
General obesity, indicated by BMI, more strongly linked to ER+/PR+ subtype
For hepatitis B virus carriers

HBcrAg Levels Tied to Progression to Cirrhosis in HBV Carriers

0
After adjustment, hepatitis B virus core-related antigen was independently linked to progression
Insurers have the bargaining power to reduce provider prices in highly concentrated provider markets

Insurer Market Power Lowers Providers’ Prices

0
Evidence seen for specialists in markets with high provider, insurer concentration